Exelixis, Inc. v. Intas Pharmaceuticals Ltd. et al
| Exelixis, Inc. |
| Intas Pharmaceuticals Ltd. and Accord Healthcare, Inc. |
| 1:2026cv00814 |
| July 6, 2026 |
| U.S. District Court for the District of Delaware |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 7, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 6 Summons Issued as to Accord Healthcare, Inc. on 7/7/2026; Intas Pharmaceuticals Ltd. on 7/7/2026. (Attachments: #1 Summons Issued)(scs) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Exelixis, Inc.. (scs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776 B2; 11,091,439 B2; 11,091,440 B2; 11,098,015 B2 ; 12,128,039 B2. (scs) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 26, 2026. Date of Expiration of Patent: October 8, 2030, January 15, 2030, February 10, 2032.Thirty Month Stay Deadline: 11/26/2028. (scs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) |
| Filing 1 COMPLAINT for Patent Infringement against Accord Healthcare, Inc., Intas Pharmaceuticals Ltd. (Filing fee $ 405, receipt number ADEDC-5009039) - filed by Exelixis, Inc.. (Attachments: #1 Exhibits A-E, #2 Civil Cover Sheet)(scs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
